Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 12/20 | 1.00 |
| ▸ | CNR1 | P21554 | 11/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 7/20 | 1.00 |
| ▸ | GPR55 | Q9Y2T6 | 4/20 | 1.00 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 1.00 |
| ▸ | CYP1A1 | P04798 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 1.00 |
| ▸ | GPR6 | P46095 | 1/20 | 1.00 |
| ▸ | NAAA | Q02083 | 1/20 | 1.00 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 1.00 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 1.00 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 1.00 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 1.00 |
| ▸ | MLNR | O43193 | 1/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cannabidivarin SCHEMBL22705595 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL18371742 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL17345387 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL2759238 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL16224876 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL19477708 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL6857317 | 1.00 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| Cannabidivarin SCHEMBL10296698 | 0.93 | CNR2 (0.86) | CNR2CNR1OPRM1GPR55TRPV1 | |
| SCHEMBL23686658 | 0.92 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 | |
| SCHEMBL22705457 | 0.92 | CNR2 (1.00) | CNR2CNR1OPRM1GPR55TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 10142 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144805-A1 | CANNABIDIOL COMPOSITIONS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE AND NEUROLOGICAL DISORDERS | JAZZ PHARMACEUTICALS RESEARCH UK LIMITED (GB) | 2026-05-28 | — | — | US | claimed |
| EP-4412609-B1 | ALKOXYLATION OF CANNABIDIOL & OTHER CANNABINOIDS | INDORAMA VENTURES OXIDES LLC (US) | 2026-05-27 | — | — | EP | claimed |
| US-12636251-B1 | Glycoside-containing aqueous formulations having a lipophilic active component | Doane Technology Group LLC (US) | 2026-05-26 | — | — | US | claimed |
| US-20260137705-A1 | NOVEL CANNABINOID NANOPARTICLE COMPOSITIONS FOR THERAPEUTIC APPLICATIONS IN VETERINARY MEDICINE | Chou2 Pharma LLC (US) | 2026-05-21 | — | — | US | claimed |
| US-12629332-B2 | Cannabinoid chewing gum with sugar alcohols | NORDICCAN A/S (DK) | 2026-05-19 | — | — | US | claimed |
| EP-4740961-A2 | CANNABINOID PRODUCT FOR IMPROVING MUSCULOSKELETAL HEALTH | Lonza Greenwood LLC (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4739284-A1 | AN ADHESIVE ORAL DISC FOR SUSTAINED RELEASE OF CANNABINOIDS | Fertin Pharma A/S (DK) | 2026-05-13 | — | — | EP | claimed |
| EP-4291170-B1 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY | JAZZ PHARMACEUTICALS RESEARCH UK LTD (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4734961-A1 | NEW METHOD OF PRODUCING AN AQUEOUS MESOPARTICLE COMPOSITION COMPRISING A LIPOPHILIC COMPOUND | BIOGNTX R&D B.V. (NL) | 2026-05-06 | — | — | EP | claimed |
| US-12616728-B2 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | SUPER CRITICAL IP, LLC (US) | 2026-05-05 | — | — | US | claimed |
| WO-2005120478-A1 | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASE AND/OR SYMPTOMS IN ARTHRITIS | GW PHARMA LIMITED (GB) | 2005-12-22 | — | — | WO | claimed |
| CN-1688290-A | Cannabinoid liquid formulations for mucosal amdinistration | GW PHARMA LTD (GB) | 2005-10-26 | — | — | CN | claimed |
| US-6946150-B2 | Lipophilic medicament, a solvent and a co-solvent in an amount > 55% wt/wt of the formulation; free from self emulsifying agent and/or a fluorinated propellant; cannabinoids administered by a pump action spray | GW PHARMA LIMITED (GB) | 2005-09-20 | — | — | US | claimed |
| EP-1542657-A1 | CANNABINOID LIQUID FORMULATIONS FOR MUCOSAL AMDINISTRATION | GW Pharma Limited (GB) | 2005-06-22 | — | — | EP | claimed |
| US-20040192760-A1 | Applying lipophilic drug to surface of mucous membrane; sustained release; cannabis compound mixture; inflammatory bowel disorders; Croh's disease; analgesics; control oxidation stresses; appetites ;anticancer agents | U.S. BANK NATIONAL ASSOCIATION | 2004-09-30 | — | — | US | claimed |
| WO-2004016246-A1 | CANNABINOID LIQUID FORMULATIONS FOR MUCOSAL AMDINISTRATION | GW PHARMA LIMITED (GB) | 2004-02-26 | — | — | WO | claimed |
| US-20040034108-A1 | Lipophilic medicament, a solvent and a co-solvent in an amount > 55% wt/wt of the formulation; free from self emulsifying agent and/or a fluorinated propellant; cannabinoids administered by a pump action spray | U.S. BANK NATIONAL ASSOCIATION | 2004-02-19 | — | — | US | claimed |
| EP-1361864-A2 | MUCOADHESIVE PHARMACEUTICAL FORMULATIONS | GW Pharma Limited (GB) | 2003-11-19 | — | — | EP | claimed |
| US-20030021752-A1 | Pharmaceutical formulations | GW PHARMA LIMITED (GB) | 2003-01-30 | — | — | US | claimed |
| WO-2002064109-A2 | MUCOADHESIVE PHARMACEUTICAL FORMULATIONS | GW PHARMA LIMITED (GB) | 2002-08-22 | — | — | WO | claimed |